These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15320743)

  • 1. Pleiotropic actions of PPAR gamma activators thiazolidinediones in cardiovascular diseases.
    Takano H; Hasegawa H; Zou Y; Komuro I
    Curr Pharm Des; 2004; 10(22):2779-86. PubMed ID: 15320743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma and cardiovascular diseases.
    Takano H; Komuro I
    Circ J; 2009 Feb; 73(2):214-20. PubMed ID: 19129679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of peroxisome proliferator-activated receptor gamma in cardiovascular disease.
    Takano H; Komuro I
    J Diabetes Complications; 2002; 16(1):108-14. PubMed ID: 11872377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Timely Top Med Cardiovasc Dis; 2005 Apr; 9():E10. PubMed ID: 15830032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of PPARgamma-dependent pathway in the development of cardiac hypertrophy.
    Takano H; Hasegawa H; Nagai T; Komuro I
    Drugs Today (Barc); 2003 May; 39(5):347-57. PubMed ID: 12861348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.
    Kawahito Y; Kondo M; Tsubouchi Y; Hashiramoto A; Bishop-Bailey D; Inoue K; Kohno M; Yamada R; Hla T; Sano H
    J Clin Invest; 2000 Jul; 106(2):189-97. PubMed ID: 10903334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [PPARs and heart diseases].
    Takano H; Komuro I
    Nihon Rinsho; 2005 Apr; 63(4):659-64. PubMed ID: 15828234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS; Hattori Y; McDonald MC; Mota-Filipe H; Cuzzocrea S; Pisano B; Chatterjee PK; Thiemermann C
    FASEB J; 2002 Jul; 16(9):1027-40. PubMed ID: 12087064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
    Guo B; Koya D; Isono M; Sugimoto T; Kashiwagi A; Haneda M
    Diabetes; 2004 Jan; 53(1):200-8. PubMed ID: 14693716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity].
    Yuan ZY; Liu Y; Liu Y; Zhang JJ; Kishimoto C; Liu ZQ
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2067-72. PubMed ID: 14703419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis.
    Yuan Z; Liu Y; Liu Y; Zhang J; Kishimoto C; Wang Y; Ma A; Liu Z
    Cardiovasc Res; 2003 Sep; 59(3):685-94. PubMed ID: 14499870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S; Pisano B; Dugo L; Ianaro A; Patel NS; Di Paola R; Genovese T; Chatterjee PK; Di Rosa M; Caputi AP; Thiemermann C
    Br J Pharmacol; 2003 Sep; 140(2):366-76. PubMed ID: 12970094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
    Chinetti G; Fruchart JC; Staels B
    Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligands of the peroxisome proliferator-activated receptor-gamma and heart failure.
    Thiemermann C
    Br J Pharmacol; 2004 Jan; 141(1):1-3. PubMed ID: 14662733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of triglyceride metabolism by PPARs: fibrates and thiazolidinediones have distinct effects.
    Auwerx J; Schoonjans K; Fruchart JC; Staels B
    J Atheroscler Thromb; 1996; 3(2):81-9. PubMed ID: 9226459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptors and the control of inflammation.
    Cabrero A; Laguna JC; Vázquez M
    Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptors, orphans with ligands and functions.
    Schoonjans K; Martin G; Staels B; Auwerx J
    Curr Opin Lipidol; 1997 Jun; 8(3):159-66. PubMed ID: 9211064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS; Lewington AJ; Brunskill NJ
    Kidney Int; 2004 Jun; 65(6):2081-90. PubMed ID: 15149321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells.
    Harris SG; Phipps RP
    Immunology; 2002 Jan; 105(1):23-34. PubMed ID: 11849312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental approaches to study PPAR gamma agonists as antidiabetic drugs.
    Vázquez M; Silvestre JS; Prous JR
    Methods Find Exp Clin Pharmacol; 2002 Oct; 24(8):515-23. PubMed ID: 12500431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.